Dracunculiasis eradication: South Sudan claims interruption of transmission in humans
WHO issues recommendations on management of isoniazid-resistant tuberculosis
WHO and IFIC sign Memorandum of Understanding
Seven years of Syria’s health tragedy
Egypt: first country in Eastern Mediterranean region to eliminate lymphatic filariasis
WHO issues new guidance on tobacco product regulation towards maximum protection of public health
New member of ICTRP Partner Registry Network: Acupuncture-Moxibustion Clinical Trial Registry (AMCTR)
ICTRP dataset in CSV format
61st session of the Commission on Narcotic Drugs
Ensuring the right to health of every adolescent
Gender equality must be at the core of 'Health for All'
OpenWHO courses bring new focus to Pandemic Influenza Preparedness
May 2018 nursing and midwifery meetings
WHO and the Stop TB Partnership join hands to rally Heads of States to End TB
Eradicating dracunculiasis: WHO certifies Kenya as South Sudan and Mali continue to report zero human cases
Cryptococcal disease: what's new and important
WHO launches the hearWHO app for mobile devices to help detect hearing loss
WHO supports response to the suspected meningitis outbreak in Torit County, South Sudan
Mozambique implementing the Global Leprosy Strategy 2016–2020
Statement for Rare Disease Day
Report of the WHO Webinar for Civil Society and Partners on TB Guidelines Development
Nursing Now Campaign
Eliminating dog-mediated human rabies: Karachi determined to overcome a public health hazard
WHO and USAID release guide to support countries in developing national action plans on public-private mix for TB prevention and care
INFOSAN in action to control an outbreak of salmonellosis linked to infant formula
WHO issues new recommendations calling for accelerated uptake of testing and treatment for TB prevention
New member of the Primary Registry Network: Acupuncture-Moxibustion Clinical Trial Registry (AMCTR)
From bites to bytes
MedMon - WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application
Public call for individual patient data on treatment of rifampicin and multidrug-resistant (MDR/RR-TB) tuberculosis
